ethyl (4-methoxycarbonyl)thiophene-3-carbamate | 118252-16-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 英文名称: ethyl (4-methoxycarbonyl)thiophene-3-carbamate
• 英文别名: methyl 4-(ethoxycarbonylamino)-thiophene-3-carboxylate；methyl (4-ethoxycarbonylamino)-3-thiophenecarboxylate；methyl 4-(ethoxycarbonylamino)thiophene-3-carboxylate
• CAS: 118252-16-7
• 化学式: C₉H₁₁NO₄S
• 分子量: 229.257
• InChiKey: BTUCIRLDSZEPAG-UHFFFAOYSA-N

物化性质

• 熔点：
  49-52 °C
• 沸点：
  296.1±25.0 °C(Predicted)
• 密度：
  1.327±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  92.9
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  ethyl (4-methoxycarbonyl)thiophene-3-carbamate 在 manganese(IV) oxide 、 lithium aluminium tetrahydride 作用下， 生成 4-(ethoxycarbonylamino)-thiophene-3-carboxaldehyde
  参考文献：
  名称：

  缩合的噻吩并嘧啶类。IV。2,3-二氢-5H-恶唑基硫代嘧啶衍生物的合成及胃抗分泌活性。

  摘要：

  2,3-二氢-5H-恶唑并[3,2-a] thieno [3,2-d]-（2a--d），[3,4-d]-（2e--h）和[2合成了3-，3-d]嘧啶衍生物（2i，j），并评估了其胃的抗分泌活性。从甲硫基噻吩氨基甲酸酯（4）开始逐步制备这些类似物（2）。讨论了这些化合物的构效关系。

  DOI：

  10.1248/cpb.37.2717
• 作为产物：
  描述：

  methyl 4-(ethoxycarbonylamino)-1-oxo-2,3-dihydrothiophene-3-carboxylate 生成 ethyl (4-methoxycarbonyl)thiophene-3-carbamate
  参考文献：
  名称：

  RIPPEL, ROBERT;FLEMMING, HANS-WOLFRAM;RUKWIED, MANFRED

  摘要：

  DOI：

文献信息

• Modified aminoacids, pharmaceuticals containing these compounds and method for their production
  申请人：Dr. Karl Thomae GmbH

  公开号：US06344449B1

  公开（公告）日：2002-02-05

  The present invention relates to modified amino acids of general formula wherein A, Z, X, n, m, R, R2, R3, R4 and R11 are defined as in claims 1 to 5, their tautomers, their diastereomers, their enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, pharmaceutical compositions containing these compounds, the use thereof and processes for preparing them as well as their use for the production and purification of antibodies and as labelled compounds in RIA- and ELISA assays and as diagnostic or analytical aids in neurotransmitter research.

  本发明涉及一般式的改性氨基酸 其中 A、Z、X、n、m、R、R2、R3、R4和R11的定义如权利要求1至5中所述，它们的互变异构体、对映异构体、立体异构体、它们的混合物及其盐，特别是其与无机或有机酸或碱的生理上可接受的盐，含有这些化合物的药物组合物，其用途以及制备它们的过程，以及它们在抗体的生产和纯化中的用途以及在RIA和ELISA测定中作为标记化合物以及在神经递质研究中作为诊断或分析辅助工具的用途。
• Modified amino acids, pharmaceuticals containing these compounds and method for their production
  申请人：——

  公开号：US20010036946A1

  公开（公告）日：2001-11-01

  The present invention relates to modified amino acids of general formula 1 wherein A, Z, X, n, m, R, R 2 , R 3 , R 4 and R 11 are defined as in claims 1 to 5 , their tautomers, their diastereomers, their enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, pharmaceutical compositions containing these compounds, the use thereof and processes for preparing them as well as their use for the production and purification of antibodies and as labelled compounds in RIA- and ELISA assays and as diagnostic or analytical aids in neurotransmitter research.

  本发明涉及一般式1的改良氨基酸，其中A、Z、X、n、m、R、R2、R3、R4和R11如权利要求1至5中所定义，它们的互变异构体、对映异构体、混合物及其盐，特别是其与无机或有机酸或碱的生理上可接受的盐，含有这些化合物的药物组合物，其用途以及用于制备它们的过程，以及它们在抗体的生产和纯化中的用途，以及在RIA和ELISA测定中作为标记化合物以及在神经递质研究中作为诊断或分析辅助工具的用途。
• Condensed thienopyrimidines. I. Synthesis and gastric antisecretory activity of 2,3-dihydro-5H-oxazolothienopyrimidin-5-one derivatives.
  作者：Mitsuo SUGIYAMA、Toshiaki SAKAMOTO、Keiichi TABATA、Kazuo ENDO、Keiichi ITO、Mitsuko KOBAYASHI、Hiroshi FUKUMI

  DOI：10.1248/cpb.37.2091

  日期：——

  A practical preparation of various 2, 3-dihydro-5H-oxazolo[3, 2-a]thieno[3, 2-d]-, [3, 4-d]-, and [2, 3-d]pyrimidin-5-one derivatives was developed starting from the corresponding aminothiopheneesters in two steps, and their chloro-substituted derivatives were prepared. These compounds were evaluated for gastric antisecretory activity in pylorus-ligated rats, compared to the anti-ulcer standard, cimetidine, and their structure-activity relationships are discussed.

  一种实用的方法被开发用于合成多种2, 3-二氢-5H-噁唑并噻吩的[3, 2-a]、[3, 4-d]和[2, 3-d]嘧啶-5-酮衍生物，该过程从相应的氨基噻吩酯出发，仅需两步，并且其氯取代衍生物也被合成。这些化合物在幽门结扎大鼠中评估了其抗胃分泌活性，并与抗溃疡标准药物西咪替丁进行了比较，同时讨论了它们的结构-活性关系。
• Russell, Roland K.; Rampulla, Richard A.; Nievelt, Caroline E. van, Journal of Heterocyclic Chemistry, 1990, vol. 27, # 6, p. 1761 - 1770
  作者：Russell, Roland K.、Rampulla, Richard A.、Nievelt, Caroline E. van、Klaubert, Dieter H.

  DOI：——

  日期：——
• Preparation of <i>N</i>-1 Substituted Thieno[3,4-<i>d</i>]pyrimidine-2,4-diones
  作者：Ronald K. Russell、Caroline E. van Nievelt、Richard A. Rampulla、Dieter H. Klaubert

  DOI：10.1080/00397919208021136

  日期：1992.12

  The preparation of N-1 substituted thieno[3,4-d]pyrimidine-2,4-diones is presented. The key feature of this synthesis is the use of a 2,4-dimethoxybenzyl protecting group at N-3 that was readily removed in methanesulfonic acid.